Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena

Vaccine

Volumn 32, Issue 25, 2014, Pages 2995-3003

  Trus, Ivan ^a   Bonckaert, Caroline ^a   van der Meulen, Karen ^a   Nauwynck, Hans J ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PORCILIS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEVER; NONHUMAN; NOSE SECRETION; PRIORITY JOURNAL; VACCINATION; VIREMIA; VIRUS ATTENUATION; VIRUS SHEDDING; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS PROTECTION; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUS SCROFA; SWINE; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA; VIRUS SHEDDING;

EID: 84899945313     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.077     Document Type: Article

References (31)

1. Chand R.J., Trible B.R., Rowland R.R.R. Pathogenesis of porcine reproductive and respiratory syndrome virus. Curr Opin Virol 2012, 2:256-263. (PubMed PMID: 22709514).
2. Karniychuk U.U., Geldhof M., Vanhee M., Van Doorsselaere J., Saveleva T.A., Nauwynck H.J. Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate. BMC Vet Res 2010, 6:30. (PubMed PMID: 20525333).
3. Van Gucht S., Labarque G., Van Reeth K. The combination of PRRS virus and bacterial endotoxin as a model for multifactorial respiratory disease in pigs. Vet Immunol Immunop 2004, 102:165-178. (PubMed PMID: 15507303).
4. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc 2005, 227:385-392. (PubMed PMID: 16121604).
5. Mardassi H., Mounir S., Dea S. Identification of major differences in the nucleocapsid protein genes of a Québec strain and European strains of porcine reproductive and respiratory syndrome virus. J Gen Virol 1994, 75:681-685. (PubMed PMID: 8126467).
6. Stadejek T., Oleksiewicz M.B., Scherbakov A.V., Timina A.M., Krabbe J.S., Chabros K., et al. Definition of subtypes in the European genotype of porcine reproductive and respiratory syndrome virus: nucleocapsid characteristics and geographical distribution in Europe. Arch Virol 2008, 153:1479-1488. (PubMed PMID: 18592131).
7. Labarque G.G., Nauwynck H.J., Van Reeth K., Pensaert M.B. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. J Gen Virol 2000, 81:1327-1334. (PubMed PMID: 10769076).
8. Frydas I., Verbeeck M., Cao J., Nauwynck H.J. Replication characteristics of porcine reproductive and respiratory syndrome virus (PRRSV) European subtype 1 (Lelystad) and subtype 3 (Lena) strains in nasal mucosa and cells of the monocytic lineage: indications for the use of new receptors of PRRSV (Lena). Vet Res 2013, 44:73. (PubMed PMID: 24007551).
9. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 2004, 102:155-163. (PubMed PMID: 15507302).
10. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32:648-660. (PMID: 8592800).
11. Quinn P.J. Clinical Veterinary Microbiology 1994, Mosby, London, UK.
12. Vanhee M., Delputte P.L., Delrue I., Geldhof M.F., Nauwynck H.J. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies. Vet Res 2009, 40:63. (PubMed PMID: 19674539).
13. Labarque G., Van Gucht S., Van Reeth K., Nauwynck H., Pensaert M. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet Microbiol 2003, 95:187-197. (PubMed PMID: 12935746).
14. Kirkwood B.R., Sterne J.A.C. Essential Medical Statistics 2003, Blackwell Publishing Ltd., Oxford, UK.
15. Murtaugh M. Use and interpretation of sequencing in PRRSV control programs. Proceedings of the Allen D. Leman Swine Conference 2012, 49-55. 39.
16. Weesendorp E., Morgan S., Stockhofe-Zurwieden N., Popma-De Graaf D.J., Graham S.P., Rebel J.M. Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence. Vet Microbiol 2013, 163:1-12. (PubMed PMID: 23036445).
17. Kimman T.G., Cornelissen L.A., Moormann R.J., Rebel J.M., Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009, 27:3704-3718. (PubMed PMID: 19464553).
18. Geldhof M.F., Vanhee M., Van Breedam W., Van Doorsselaere J., Karniychuk U.U., Nauwynck H.J. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges. BMC Vet Res 2012, 8:182. (PubMed PMID: 23031319).
19. Costers S., Lefebvre D.J., Goddeeris B., Delputte P.L., Nauwynck H.J. Functional impairment of PRRSV-specific peripheral CD3+CD8high cells. Vet Res 2009, 40:46. (PubMed PMID: 19445889).
20. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vaccine Immunol 2007, 14:269-275. (PubMed PMID: 17215336).
21. Vanhee M., Van Breedam W., Costers S., Geldhof M., Noppe Y., Nauwynck H. Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies. Vaccine 2011, 29:4794-4804. (PubMed PMID: 21554913).
22. de Lima M., Pattnaik A.K., Flores E.F., Osorio F.A. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology 2006, 353:410-421. (PubMed PMID: 16843516).
23. Oleksiewicz M.B., Bøtner A., Toft P., Normann P., Storgaard T. Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. J Virol 2001, 75:3277-3290. (PubMed PMID: 11238854).
24. Nauwynck H.J., Van Gorp H., Vanhee M., Karniychuk U., Geldhof M., Cao A., et al. Micro-dissecting the pathogenesis and immune response of PRRSV infection paves the way for more efficient PRRSV vaccines. Transbound Emerg Dis 2012, 59:50-54. (PubMed PMID: 22225918).
25. Cao J., Grauwet K., Vermeulen B., Devriendt B., Jiang P., Favoreel H., et al. Suppression of NK cell-mediated cytotoxicity against PRRSV-infected porcine alveolar macrophages in vitro. Vet Microbiol 2013, 164:261-269. (PubMed PMID: 23522639).
26. Bøtner A., Strandbygaard B., Sørensen K.J., Have P., Madsen K.G., Madsen E.S., et al. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet Rec 1997, 141:497-499. (PubMed PMID: 9402722).
27. Mengeling W.L., Lager K.M., Vorwald A.C. Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome. Am J Vet Res 1999, 60:796-801. (PubMed PMID: 10407469).
28. Zuckermann F.A., Garcia E.A., Luquec I.D., Christopher-Hennings J., Dostere A., Britoe M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol 2007, 123:69-85. (PubMed PMID: 17376612).
29. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 2004, 22:4183-4190. (PubMed PMID: 15474708).
30. Scortti M., Prieto C., Simarro I., Castro J.M. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus. Theriogenology 2006, 66:1884-1893. (PubMed PMID: 16806451).
31. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Bøtner A., Storgaard T. Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 2001, 82:1263-1272. (PubMed PMID: 11369869).